Y Biologics

The Tesla Model Y reclaimed the top spot on the best-selling imported car list in South Korea last month for the first time since September 2022. Th...

South Korea’s Lotte Biologics Co. is set to start building its first local facility for drug manufacturing next year, aiming for 400,000 liter...

Prestige Biologics Co., a South Korean biopharmaceutical contract development and manufacturing organization (CDMO) company, is expanding its CDMO b...

Samsung Biologics Co., the world’s largest contract drugmaker, said on Monday it has signed an agreement to produce $242 million worth of anti...

Tires tailored for electric vehicles are expected to become the next cash cow of South Korean tire maker Kumho Tire Co. thanks to growing EV tire or...

SK Pharmteco Co., South Korean conglomerate SK Group’s contract development and manufacturing organization (CDMO), is upping the ante in its b...

South Korean molecular diagnostics company Novomics Co. announced on Wednesday that it has signed a collaboration agreement with Chinese molecular d...

Samsung Biologics Co., the world’s top contract manufacturing organization by capacity, inked a $391 million contract from Novartis, nearly fi...

South Korea’s No. 1 biopharmaceutical company Samsung BioLogics Co. and No. 2 Celltrion Inc. produced higher CO2 emissions last year than in 2...

Samsung Biologics Co., the world’s largest contract manufacturing organization (CMO) in terms of production capacity, said on Tuesday it has w...

Samsung Biologics Co., the world’s No. 1 contract drugmaker, announced a groundbreaking strategic partnership with Pfizer on Thursday, marking...

BOSTON – Samsung Biologics Co., the world’s No. 1 contract drugmaker, plans to more than double its total annual production capacity to ...

More than 500 South Korean companies from top business groups to AI-based biotech startups are slated to attend the Bio International Convention 202...

Samsung Group leader Lee Jay-yong has met with Tesla Inc. Chief Executive Elon Musk to discuss a tech alliance between the two companies in a variet...

Bertis, South Korean company specializing in the development of proteomics-based precision medicine technology, announced on Monday that it presente...

Samsung Group leader Lee Jae-yong, currently in the US, has vowed to make biotechnology the conglomerate’s second core strategic business afte...

South Korea’s Lotte Biologics Co. said on Friday that it has made an equity investment in Pinotbio, Inc. for the development of antibody-drug ...

South Korea’s Lotte Biologics Co. held a plaque ceremony on Monday to commemorate the acquisition of a pharmaceutical production plant from Br...

Lotte Biologics, South Korea's biopharmaceutical contract development and manufacturing organization (CDMO) company, announced on Sunday that it has...

Samsung Electronics Co. Chairman Jay Y. Lee arrived in Beijing on March 23 to review the chipmaker’s business in China, which is gradually rec...

Hyundai Motor Group Chairman Chung Euisun was ranked as South Korea’s highest-paid business owner in 2022 thanks to the group's record-high pr...

Samsung Biologics Co. is slated to inject 2 trillion won ($1.5 billion) to build its fifth plant in South Korea. It will be a fast follow-up investm...

Prestige Biologics Co., a South Korean biopharmaceutical contract development and manufacturing organization (CDMO) company, announced on Tuesday th...

BEIJING – Samsung Group leader Jay Y. Lee plans to attend the China Development Forum later this month for the first time as the South Korean ...

“I want to actively participate in volunteer work but it isn't easy because my face is known.”Samsung Electronics Co. Chairman Jay Y. Le...

Samsung Biologics Co., the world’s No. 1 contract drug maker in terms of production capacity, has won a $182.7 million contract manufacturing ...

Samsung Electronics Co. has partnered with the Korea Advanced Institute of Science and Technology (KAIST) to cultivate specialists in robotics. On M...

Rank-and file-employees at Samsung Electronics Co. will call their senior executives without their titles as part of the company’s new human r...

Samsung Biologics Co., the world’s top contract drugmaker, said its profit almost doubled last year thanks to more orders as its sales surged ...

John Rim, chief executive of Samsung BioLogics will directly lead his company's global sales operations for biopharmaceuticals through contract deve...